Abstract Submission Deadline: 5:00 pm CT on December 1, 2020
Accepted abstracts will be published in the Journal of Thrombosis and Thrombolysis. To be considered for review, abstracts must be submitted no later than 5:00 pm CT on December 1, 2020.
All abstracts are limited to a total of 250 words excluding the title, authors, and affiliations. Please complete your submission carefully. All abstracts must be in final form. No typos or other errors can be corrected after the deadline. Abstracts will not be considered or reviewed unless all required fields are completed. Authors may edit abstracts online as long as they meet the submission deadline.
All correspondence, including notification of abstract acceptance and details for poster presentations, will be sent to the Corresponding Author (submitting author) via email. The corresponding author shall be responsible for informing all contributing authors of any related correspondence. All first authors must register for the meeting in order to present their poster.
The presenting author has the responsibility of obtaining the consent of all coauthors to be listed on the submitted abstract.
The data reported in the abstract should represent original research. Case studies and research with preliminary results are accepted.
Abstracts reporting studies with unidentified chemical compounds, drugs, or materials will not be accepted.
Abstract submission signifies that the reported research complies with animal welfare and human subject regulations.
Abstract submission signifies permission to post the abstract on the AC Forum web site.
The abstract itself should contain the following components:
The title should accurately reflect the information presented in the body of the abstract.
The beginning of the abstract should state the hypothesis, purpose or scientific objective of the study. The remainder of the abstract should address this hypothesis, purpose or scientific objective.
The abstract should describe the study, design, subjects and analytic procedures. The method described should unquestionably address the stated hypothesis, purpose or objective. Include enough detail to enable the Program Committee to gain a clear understanding of the methodology.
The results should be summarized in sufficient detail to support the final conclusion. If applicable, the mean results should be presented in numerical fashion with deviations or standard errors on the mean. Number of animals, studies or patients should be noted. Present the data in sufficient detail for the reader to form conclusions and acknowledge (or disagree with) the interpretation of the author’s analysis.
The abstract should close with a brief statement of the conclusion(s). Do not overstate conclusions. Make certain that all conclusions follow logically from the data and that the data presented confirms, refutes or modifies the purpose or the specific objectives of the study in the introductory sentence.
Each submitted abstract will be evaluated by the Program Committee for scientific merit and compliance with the guidelines described above. Abstracts that do not conform to the above standards may be rejected.